Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-005093)

Filing Details

Accession Number:: 0001209191-23-005093
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-26 17:23:09
Reporting Period:: 2023-01-26

Accepted Time:: 2023-01-26 17:23:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780556	David Jakeman	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-26	3,230	$1.76	136,752	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 23, 2019, January 21, 2020, January 22, 2021 and January 18, 2022. The sales of the shares were made pursuant to automatic sell-to-cover arrangements adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grants of such restricted stock unit awards.